Connect with us

News

Covaxin shows 50% effectiveness against symptomatic Covid-19 in real-world assessment: Lancet study

Published

on

NEW DELHI: Two doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
The results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.
The latest study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from April 15–May 15, who were symptomatic and underwent RT-PCR test for Covid-19 detection.
Researchers noted that the Delta variant was the dominant strain in India during the study period, accounting for approximately 80 per cent of all confirmed Covid-19 cases.
Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology, Indian Council of Medical Research (NIV-ICMR), Pune, is an inactivated whole virus vaccine administered in a two-dose regimen, 28 days apart.
In January this year, Covaxin was approved for emergency use in India for people aged 18 and above. The World Health Organization (WHO) added the vaccine to its list of approved emergency use Covid-19 vaccines earlier this month.
The latest study was conducted during India’s second Covid-19 surge and in healthcare workers who were primarily offered Covaxin.
“Our study offers a more complete picture of how BBV152 (Covaxin) performs in the field and should be considered in the context of COVID-19 surge conditions in India, combined with the possible immune evasive potential of the Delta variant,” said Manish Soneja, Additional Professor of Medicine at AIIMS New Delhi.
“Our findings add to the growing body of evidence that rapid vaccine rollout programmes remain the most promising path to pandemic control while public health policies must continue to include additional protective measures, such as mask-wearing and social distancing,” Soneja said in a statement.
The COVID-19 vaccination centre at AIIMS New Delhi exclusively offered Covaxin beginning January 16 this year to all of its 23,000 employees.
Researchers evaluated the effectiveness of the vaccine against symptomatic RT-PCR confirmed SARS-CoV-2 infection.
Of the 2,714 employees in the study population, 1,617 people tested positive for SARS-CoV-2, the virus that causes COVID-19, and 1,097 tested negative.
Positive cases were matched to negative RT-PCR tests (controls).
The odds of vaccination with Covaxin were compared between cases and controls and adjusted for occupational exposure to COVID-19, previous SARS-CoV-2 infection, and infection dates.
The study found that the vaccine effectiveness against symptomatic COVID-19 after two doses of Covaxin with the second dose administered 14 or more days before undergoing RT-PCR testing was 50 per cent.
The effectiveness of two vaccine doses remained stable over the seven-week follow-up period, the researchers said.
The adjusted vaccine effectiveness of the first dose, estimated after seven and 21 days, was low, which is consistent with the performance of other preventives against the Delta variant, they said.
“Findings from the study confirm previous research indicating that two doses of BBV152 are required to achieve maximum protection and that all vaccine roll-out plans must follow the recommended dosing schedule,” said Parul Kodan, Assistant Professor of Medicine at AIIMS New Delhi.
“More research is needed to better understand how these findings translate to BBV152’s effectiveness against delta and other variants of concern, especially related to severe COVID-19 infection, hospitalisation, and deaths,” Kodan said.
The authors acknowledge that the vaccine effectiveness of Covaxin estimated in this study is lower than the efficacy reported by the recently published phase 3 trial. They noted that several factors may be responsible for the lower vaccine effectiveness in the latest study.
The researchers said this study population only included hospital employees who may have a higher risk of exposure to COVID-19 infection than the general population.
The research was conducted during the peak of India’s second wave of COVID-19 with high test positivity rates for both hospital employees and residents of Delhi, they said.
Prevalence of circulating variants of concern, especially Delta, may have also contributed to the vaccine’s lower effectiveness, according to the researchers.
The authors acknowledge several limitations to their study.
The study does not estimate the vaccine effectiveness against hospitalisation, severe disease, and death, which require further assessment, they noted.
Also, the study was not designed to estimate vaccine effectiveness for different time intervals after vaccination or to determine if vaccine effectiveness changed over time, the researchers added.

News

Squatter couple buy Blackbird Close plot Bradwell

Published

on

Published:
1:34 PM November 30, 2021



Updated:
1:59 PM November 30, 2021

A Bradwell couple have sealed the deal on a parcel of land ahead of a crucial planning meeting to decide if they can use it as their private garden.

Donna and Kent Barron will be submitting documents to the Land Registry in the next few days after closing the sale with the original builders of their property on Monday.

They took “adverse possession” of the plot in Blackbird Close and fenced off a portion of it around three years ago, effectively making them squatters after they failed to locate the owner despite extensive enquiries.

In August they received a letter from Great Yarmouth Borough Council enforcement officers asking them to apply for planning permission for a change of use,  or take the fence down.


Land at Blackbird Close Bradwell squatters planning issue

Donna and Kent Barron have been using part of the land as their garden under squatters rights, but have now bought it.
– Credit: Liz Coates

A decision is due at the council’s next development control meeting on December 8.

In the meantime following years of investigations to find the legal owners Mrs Barron went back through the paperwork and found a trail leading to 1983 proving that builders WM Tubby had bought the land in February from Guyton’s.

At the time a pylon stood on the plot and it was never registered, although Eastern Power Networks had placed a caution on it.

Mr Barron then wrote to the directors asking for help and was able to buy the land for an undisclosed sum at the eleventh hour.

He said it made their case “absolute” and hoped planners would look favourably on their change-of-use bid.


Blackbird Close bid to turn land into private garden


Donna and Kent Barron have turned a patch of wasteland into a private garden after exhaustive attempts to find out who owned it.

– Credit: Liz Coates

They now own the entire plot, including the portion not fenced in.

Documents uploaded to the borough council’s planning portal include an invoice for the sale.

Borough council leader Carl Smith has objected to the change of use citing loss of informal public open space and the risk of setting a precedent such as in large open-plan post-war housing estates.

Deputy leader Graham Plant echoed Mr Smith’s statement and requested to speak at the meeting.

Bradwell Parish Council has registered a holding objection “until such time as legal ownership of this land is resolved” adding that it intended to put a bus stop on the land.

One neighbour has objected saying allowing the change of use would “reward bad behaviour”.

To view the documents visit the borough council’s planning portal using reference 06/21/0766/CU.

Continue Reading

News

Pretty Little Liars Star Lucy Hale Fully Supports Cast of Reboot Show – Screen Rant

Published

on

Pretty Little Liars Star Lucy Hale Fully Supports Cast of Reboot Show  Screen Rant

Continue Reading

News

The Howling 4K Blu-ray Release Date and Bonus Content Revealed – Collider.com

Published

on

The Howling 4K Blu-ray Release Date and Bonus Content Revealed  Collider.com

Continue Reading

Trending